• Something wrong with this record ?

Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis

P. Filip, A. Svatkova, AF. Carpenter, LE. Eberly, I. Nestrasil, MJ. Nissi, S. Michaeli, S. Mangia

. 2020 ; 26 (-) : 102234. [pub] 20200302

Language English Country Netherlands

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
P30 NS076408 NINDS NIH HHS - United States
P41 EB027061 NIBIB NIH HHS - United States
KL2 TR000113 NCATS NIH HHS - United States
UL1 TR002494 NCATS NIH HHS - United States
UL1 TR000114 NCATS NIH HHS - United States
KL2 TR002492 NCATS NIH HHS - United States
S10 OD017974 NIH HHS - United States
P41 EB015894 NIBIB NIH HHS - United States

Even though MRI visualization of white matter lesions is pivotal for the diagnosis and management of multiple sclerosis (MS), the issue of detecting diffuse brain tissue damage beyond the apparent T2-hyperintense lesions continues to spark considerable interest. Motivated by the notion that rotating frame MRI methods are sensitive to slow motional regimes critical for tissue characterization, here we utilized novel imaging protocols of rotating frame MRI on a clinical 3 Tesla platform, including adiabatic longitudinal, T1ρ, and transverse, T2ρ, relaxation methods, and Relaxation Along a Fictitious Field (RAFF) in the rotating frame of rank 4 (RAFF4), in 10 relapsing-remitting multiple sclerosis patients and 10 sex- and age-matched healthy controls. T1ρ, T2ρ and RAFF4 relaxograms extracted from the whole white matter exhibited a significant shift towards longer relaxation time constants in MS patients as compared to controls. T1ρ and RAFF4 detected alterations even when considering only regions of normally appearing white matter (NAWM), while other MRI metrics such as T1w/T2w ratio and diffusion tensor imaging measures failed to find group differences. In addition, RAFF4, T2ρ and, to a lesser extent, T1ρ showed differences in subcortical grey matter structures, mainly hippocampus, whereas no functional changes in this region were detected in resting-state functional MRI metrics. We conclude that rotating frame MRI techniques are exceptionally sensitive methods for the detection of subtle abnormalities not only in NAWM, but also in deep grey matter in MS, where they surpass even highly sensitive measures of functional changes, which are often suggested to precede detectable structural alterations. Such abnormalities are consistent with a wide spectrum of different, but interconnected pathological features of MS, including the loss of neuronal cells and their axons, decreased levels of myelin even in NAWM, and altered iron content.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012994
003      
CZ-PrNML
005      
20210507103917.0
007      
ta
008      
210420s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nicl.2020.102234 $2 doi
035    __
$a (PubMed)32272373
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Filip, Pavel $u First Department of Neurology, Faculty of Medicine, Masaryk University and University Hospital of St. Anne, Brno, Czech Republic; Department of Radiology, Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, MN, USA
245    10
$a Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis / $c P. Filip, A. Svatkova, AF. Carpenter, LE. Eberly, I. Nestrasil, MJ. Nissi, S. Michaeli, S. Mangia
520    9_
$a Even though MRI visualization of white matter lesions is pivotal for the diagnosis and management of multiple sclerosis (MS), the issue of detecting diffuse brain tissue damage beyond the apparent T2-hyperintense lesions continues to spark considerable interest. Motivated by the notion that rotating frame MRI methods are sensitive to slow motional regimes critical for tissue characterization, here we utilized novel imaging protocols of rotating frame MRI on a clinical 3 Tesla platform, including adiabatic longitudinal, T1ρ, and transverse, T2ρ, relaxation methods, and Relaxation Along a Fictitious Field (RAFF) in the rotating frame of rank 4 (RAFF4), in 10 relapsing-remitting multiple sclerosis patients and 10 sex- and age-matched healthy controls. T1ρ, T2ρ and RAFF4 relaxograms extracted from the whole white matter exhibited a significant shift towards longer relaxation time constants in MS patients as compared to controls. T1ρ and RAFF4 detected alterations even when considering only regions of normally appearing white matter (NAWM), while other MRI metrics such as T1w/T2w ratio and diffusion tensor imaging measures failed to find group differences. In addition, RAFF4, T2ρ and, to a lesser extent, T1ρ showed differences in subcortical grey matter structures, mainly hippocampus, whereas no functional changes in this region were detected in resting-state functional MRI metrics. We conclude that rotating frame MRI techniques are exceptionally sensitive methods for the detection of subtle abnormalities not only in NAWM, but also in deep grey matter in MS, where they surpass even highly sensitive measures of functional changes, which are often suggested to precede detectable structural alterations. Such abnormalities are consistent with a wide spectrum of different, but interconnected pathological features of MS, including the loss of neuronal cells and their axons, decreased levels of myelin even in NAWM, and altered iron content.
650    _2
$a dospělí $7 D000328
650    _2
$a mozek $x patologie $7 D001921
650    _2
$a průřezové studie $7 D003430
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a interpretace obrazu počítačem $x metody $7 D007090
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a relabující-remitující roztroušená skleróza $x diagnostické zobrazování $x patologie $7 D020529
650    _2
$a neurozobrazování $x metody $7 D059906
650    _2
$a bílá hmota $x diagnostické zobrazování $x patologie $7 D066127
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Svatkova, Alena $u Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA; Department of Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria
700    1_
$a Carpenter, Adam F $u Department of Neurology, School of Medicine, University of Minnesota, Minneapolis, MN, USA
700    1_
$a Eberly, Lynn E $u Department of Radiology, Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, MN, USA; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA
700    1_
$a Nestrasil, Igor $u Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA
700    1_
$a Nissi, Mikko J $u Department of Applied Physics, University of Eastern Finland, Kuopio, Finland
700    1_
$a Michaeli, Shalom $u Department of Radiology, Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, MN, USA
700    1_
$a Mangia, Silvia $u Department of Radiology, Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, MN, USA. Electronic address: mangia@umn.edu
773    0_
$w MED00188130 $t NeuroImage. Clinical $x 2213-1582 $g Roč. 26, č. - (2020), s. 102234
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32272373 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103916 $b ABA008
999    __
$a ok $b bmc $g 1651223 $s 1133373
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 26 $c - $d 102234 $e 20200302 $i 2213-1582 $m NeuroImage. Clinical $n Neuroimage Clin $x MED00188130
GRA    __
$a P30 NS076408 $p NINDS NIH HHS $2 United States
GRA    __
$a P41 EB027061 $p NIBIB NIH HHS $2 United States
GRA    __
$a KL2 TR000113 $p NCATS NIH HHS $2 United States
GRA    __
$a UL1 TR002494 $p NCATS NIH HHS $2 United States
GRA    __
$a UL1 TR000114 $p NCATS NIH HHS $2 United States
GRA    __
$a KL2 TR002492 $p NCATS NIH HHS $2 United States
GRA    __
$a S10 OD017974 $p NIH HHS $2 United States
GRA    __
$a P41 EB015894 $p NIBIB NIH HHS $2 United States
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...